Advertisement
Canada markets closed
  • S&P/TSX

    21,885.38
    +11.66 (+0.05%)
     
  • S&P 500

    5,048.42
    -23.21 (-0.46%)
     
  • DOW

    38,085.80
    -375.12 (-0.98%)
     
  • CAD/USD

    0.7324
    +0.0000 (+0.00%)
     
  • CRUDE OIL

    83.84
    +0.27 (+0.32%)
     
  • Bitcoin CAD

    88,064.07
    +302.05 (+0.34%)
     
  • CMC Crypto 200

    1,390.69
    +8.11 (+0.59%)
     
  • GOLD FUTURES

    2,347.80
    +5.30 (+0.23%)
     
  • RUSSELL 2000

    1,981.12
    -14.31 (-0.72%)
     
  • 10-Yr Bond

    4.7060
    +0.0540 (+1.16%)
     
  • NASDAQ futures

    17,773.00
    +205.50 (+1.17%)
     
  • VOLATILITY

    15.37
    -0.60 (-3.76%)
     
  • FTSE

    8,078.86
    +38.48 (+0.48%)
     
  • NIKKEI 225

    37,799.05
    +170.57 (+0.45%)
     
  • CAD/EUR

    0.6825
    +0.0004 (+0.06%)
     

A small trial for a male birth control pill was successful—if you’re okay with serious sexual side effects

A small trial for a male birth control pill was successful—if you’re okay with serious sexual side effects

Arguably, a male birth control pill has been the white whale of family planning research. Although there have been several hopeful leads, obstacles like funding or adverse side effects have halted significant progress. These failures haven’t deterred scientists. Earlier this week at the annual meeting of the Endocrine Society, researchers from the University of Washington…